Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice

Journal of Clinical Investigation

Volumn 121, Issue 8, 2011, Pages 2984-2992

  Bazigou, Eleni ^a   Lyons, Oliver T A ^b,c   Smith, Alberto ^b   Venn, Graham E ^d   Cope, Celia ^c   Brown, Nigel A ^c   Makinen, Taija ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA9 INTEGRIN; EPHRIN B2; GLYCOPROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE CONTROL; GENE DELETION; GENE TARGETING; HUMAN; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VEIN VALVE;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; EPHRIN-B2; FIBRONECTINS; HUMANS; HYPERTENSION; INTEGRIN ALPHA CHAINS; LYMPHANGIOGENESIS; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PHENOTYPE; TRANSGENES; VENOUS VALVES;

EID: 79960983746     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI58050     Document Type: Article

References (32)

1. Tammela T, Alitalo K. Lymphangiogenesis: Molecular mechanisms and future promise. Cell. 2010;140(4):460-476.
2. Armstrong EJ, Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ Res. 2004;95(5):459-470. (Pubitemid 39180926)
3. Bazigou E, et al. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell. 2009;17(2):175-186.
4. Makinen T, et al. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev. 2005;19(3):397-410. (Pubitemid 40189302)
5. Petrova TV, et al. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med. 2004;10(9):974-981. (Pubitemid 39273739)
6. Norrmen C, et al. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol. 2009;185(3):439-457.
7. Lim CS, Davies AH. Pathogenesis of primary varicose veins. Br J Surg. 2009;96(11):1231-1242.
8. Fang J, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet. 2000;67(6):1382-1388.
9. Mellor RH, et al. Mutations in FOXC2 are strongly associated with primary valve failure in veins of the lower limb. Circulation. 2007;115(14):1912-1920. (Pubitemid 46598905)
10. Chang CP, et al. A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis. Cell. 2004;118(5):649-663.
11. Mellor RH, et al. Lymphatic dysfunction, not aplasia, underlies Milroy disease. Microcirculation. 2010;17(4):281-296.
12. Schlaeger TM, et al. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci U S A. 1997;94(7):3058-3063. (Pubitemid 27157263)
13. Davy A, Soriano P. Ephrin-B2 forward signaling regulates somite patterning and neural crest cell development. Dev Biol. 2007;304(1):182-193. (Pubitemid 46399684)
14. Muzumdar MD, Tasic B, Miyamichi K, Li L, Luo L. A global double-fluorescent Cre reporter mouse. Genesis. 2007;45(9):593-605. (Pubitemid 350013057)
15. Huang XZ, et al. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol. 2000;20(14):5208-5215. (Pubitemid 30431573)
16. Kampmeier OF, La Fleur Birch C. The origin and development of the venous valves with particular reference to the saphenous district. Am J Anat. 1927;38(3):451-499.
17. Caggiati A, Phillips M, Lametschwandtner A, Allegra C. Valves in small veins and venules. Eur J Vasc Endovasc Surg. 2006;32(4):447-452. (Pubitemid 44341113)
18. le Noble F, Fleury V, Pries A, Corvol P, Eichmann A, Reneman RS. Control of arterial branching morphogenesis in embryogenesis: go with the flow. Cardiovasc Res. 2005;65(3):619-628. (Pubitemid 40138982)
19. le Noble F, et al. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development. 2004;131(2):361-375. (Pubitemid 38181375)
20. Yashiro K, Shiratori H, Hamada H. Haemodynamics determined by a genetic programme govern asymmetric development of the aortic arch. Nature. 2007;450(7167):285-288. (Pubitemid 350100536)
21. Davies PF. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med. 2009;6(1):16-26.
22. Lee HJ, Koh GY. Shear stress activates Tie2 receptor tyrosine kinase in human endothelial cells. Biochem Biophys Res Commun. 2003;304(2):399-404.
23. Chlench S, et al. Regulation of Foxo-1 and the angiopoietin-2/Tie2 system by shear stress. FEBS Lett. 2007;581(4):673-680. (Pubitemid 46217926)
24. Wigle JT, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. Embo J. 2002;21(7):1505-1513. (Pubitemid 34614607)
25. Dumont DJ, et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science. 1998;282(5390):946-949. (Pubitemid 28507528)
26. Tammela T, et al. Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature. 2008;454(7204):656-660.
27. Partanen TA, et al. VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues. FASEB J. 2000;14(13):2087-2096.
28. Johnson NC, et al. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev. 2008;22(23):3282-3291.
29. Adams RH, et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999;13(3):295-306. (Pubitemid 29095801)
30. Singh P, Chen C, Pal-Ghosh S, Stepp MA, Sheppard D, Van De Water L. Loss of integrin alpha9beta1 results in defects in proliferation, causing poor re-epithelialization during cutaneous wound healing. J Invest Dermatol. 2009;129(1):217-228.
31. Muro AF, et al. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol. 2003;162(1):149-160. (Pubitemid 36859542)
32. Grunwald IC, et al. Hippocampal plasticity requires postsynaptic ephrinBs. Nat Neurosci. 2004;7(1):33-40. (Pubitemid 38032165)